ADVANCED SOLID TUMOR CANCER
Clinical trials for ADVANCED SOLID TUMOR CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID TUMOR CANCER trials appear
Sign up with your email to follow new studies for ADVANCED SOLID TUMOR CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple-Drug cocktail aims to tackle Hard-to-Treat cancers
Disease control Not yet recruitingThis study tests a combination of three drugs—tislelizumab, bevacizumab, and capecitabine—in people with advanced solid tumors. The trial focuses on two challenging groups: those whose cancers have stopped responding to immunotherapy and those with tumors that have spread to the …
Matched conditions: ADVANCED SOLID TUMOR CANCER
Phase: PHASE1, PHASE2 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New drug combo aims to block Cancer's growth signals
Disease control Not yet recruitingThis study tests two experimental oral drugs, GH55 and GH21, taken together by people with advanced solid tumors that have a specific genetic change in the MAPK pathway. The trial has two phases: first, to find the safest dose (Phase 1), and then to see if the combination can shr…
Matched conditions: ADVANCED SOLID TUMOR CANCER
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Genhouse Bio Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC